Payment overview · 2025
General Payments
$1,672.77
57 reported records · 21 companies
Healthcare provider profile · identity verified
Jonathan K West, MD
Allopathic & Osteopathic Physicians|Radiology|Vascular & Interventional Radiology · WEST COLUMBIA, SC · NPI 1184867798
Verified facts
What the public records show
CMS Open Payments records show Jonathan K West, MD received $1,672.77 in general payments during 2025 across 57 reported records.
Imperative Care, Inc accounted for 17.7% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 47 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Imperative Care, Inc | Unresolved — no canonical attribution shown | $296.58 | 17.7% | 7 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $184.96 | 11.1% | 9 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $162.64 | 9.7% | 2 | 2025 |
| Cagent Vascular INC | Unresolved — no canonical attribution shown | $141.86 | 8.5% | 5 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $98.42 | 5.9% | 4 | 2025 |
| TriSalus Life Sciences, Inc. | Unresolved — no canonical attribution shown | $91.02 | 5.4% | 2 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $85.49 | 5.1% | 3 | 2025 |
| Surmodics, Inc. | Unresolved — no canonical attribution shown | $85.08 | 5.1% | 3 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$77.87 | 4.7% | 4 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $75.38 | 4.5% | 3 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $59.10 | 3.5% | 3 | 2025 |
| ARGON MEDICAL DEVICES, INC. | Unresolved — no canonical attribution shown | $56.31 | 3.4% | 2 | 2025 |
| Baylis Medical Technologies Inc. | Unresolved — no canonical attribution shown | $52.21 | 3.1% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $39.17 | 2.3% | 2 | 2025 |
| DePuy Synthes Sales Inc. | Unresolved — no canonical attribution shown | $28.95 | 1.7% | 1 | 2025 |
| Route 92 Medical, Inc. | Unresolved — no canonical attribution shown | $28.47 | 1.7% | 1 | 2025 |
| Philips North America LLC | Unresolved — no canonical attribution shown | $26.44 | 1.6% | 1 | 2025 |
| CARDIVA MEDICAL, INC. | Unresolved — no canonical attribution shown | $23.19 | 1.4% | 1 | 2025 |
| Terumo Medical Corporation | Unresolved — no canonical attribution shown | $20.96 | 1.2% | 1 | 2025 |
| Siemens Medical Solutions USA, Inc. | Unresolved — no canonical attribution shown | $20.01 | 1.2% | 1 | 2025 |
| CORDIS US CORP. | Unresolved — no canonical attribution shown | $18.66 | 1.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $1,672.77 | 57 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| ZOOM 88-T LARGE DISTAL PLATFORM Normalized: zoom 88 t large distal platform |
Device | Imperative Care, Inc | $151.19 | 2 | 2025 |
Source payment records
|
|||||
| Serrantor Normalized: serrantor |
Device | Cagent Vascular INC | $141.86 | 5 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN Endoprosthesis with Heparin Normalized: gore viabahn endoprosthesis with heparin |
Device | W. L. Gore & Associates, Inc. | $133.80 | 1 | 2025 |
Source payment records
|
|||||
| TRINAV INFUSION SYSTEM Normalized: trinav infusion system |
Device | TriSalus Life Sciences, Inc. | $91.02 | 2 | 2025 |
Source payment records
|
|||||
| AURYON LASER SYSTEM 100-120 VAC Normalized: auryon laser system 100 120 vac |
Device | AngioDynamics, Inc. | $85.49 | 3 | 2025 |
Source payment records
|
|||||
| SYMPHONY CATHETER Normalized: symphony catheter |
Device | Imperative Care, Inc | $81.81 | 2 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy Normalized: pounce thrombectomy |
Device | Surmodics, Inc. | $61.40 | 2 | 2025 |
Source payment records
|
|||||
| Pounce Venous Thrombectomy System Normalized: pounce venous thrombectomy system |
Device | Surmodics, Inc. | $61.40 | 2 | 2025 |
Source payment records
|
|||||
| Sublime 014 Rx PTA Balloon Dilatation Catheter Normalized: sublime 014 rx pta balloon dilatation catheter |
Device | Surmodics, Inc. | $61.40 | 2 | 2025 |
Source payment records
|
|||||
| Sublime Microcatheter, 018, 200cm, Straight Normalized: sublime microcatheter 018 200cm straight |
Device | Surmodics, Inc. | $61.40 | 2 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $59.10 | 3 | 2025 |
Source payment records
|
|||||
| CLOTTRIEVER BOLD CATHETER Normalized: clottriever bold catheter |
Device | Stryker Corporation | $59.09 | 2 | 2025 |
Source payment records
|
|||||
| CLOT MANAGEMENT Normalized: clot management |
Device | ARGON MEDICAL DEVICES, INC. | $56.31 | 2 | 2025 |
Source payment records
|
|||||
| EMBOLD Fibered Normalized: embold fibered |
Device | Boston Scientific Corporation | $41.61 | 2 | 2025 |
Source payment records
|
|||||
| OSTEOCOOL RF ABLATION SYSTEM Normalized: osteocool rf ablation system |
Device | Medtronic, Inc. | $34.44 | 2 | 2025 |
Source payment records
|
|||||
| General - Embolics Normalized: general embolics |
Device | Boston Scientific Corporation | $31.29 | 2 | 2025 |
Source payment records
|
|||||
| RED 72 Normalized: red 72 |
Device | Penumbra, Inc. | $29.13 | 1 | 2025 |
Source payment records
|
|||||
| EMBOTRAP Normalized: embotrap |
Device | DePuy Synthes Sales Inc. | $28.95 | 1 | 2025 |
Source payment records
|
|||||
| N/A Normalized: n a |
Device | DePuy Synthes Sales Inc. | $28.95 | 1 | 2025 |
Source payment records
|
|||||
| Pounce Thrombectomy System Normalized: pounce thrombectomy system |
Device | Surmodics, Inc. | $28.85 | 1 | 2025 |
Source payment records
|
|||||
| GORE VIABIL Biliary Endoprosthesis Normalized: gore viabil biliary endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $28.84 | 1 | 2025 |
Source payment records
|
|||||
| ICEfx Cryoablation System Normalized: icefx cryoablation system |
Device | Boston Scientific Corporation | $28.32 | 1 | 2025 |
Source payment records
|
|||||
| Cryoablation needles Normalized: cryoablation needles |
Device | Boston Scientific Corporation | $27.69 | 1 | 2025 |
Source payment records
|
|||||
| ZOOM 7X CATHETER Normalized: zoom 7x catheter |
Device | Imperative Care, Inc | $27.47 | 1 | 2025 |
Source payment records
|
|||||
| Technical Education MRI Normalized: technical education mri |
Device | Philips North America LLC | $26.44 | 1 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $25.88 | 1 | 2025 |
Source payment records
|
|||||
| ZOOM REPERFUSION CATHETER Normalized: zoom reperfusion catheter |
Device | Imperative Care, Inc | $24.41 | 1 | 2025 |
Source payment records
|
|||||
| HI-TORQUE COMMAND Normalized: hi torque command |
Device | Abbott Laboratories | $24.06 | 1 | 2025 |
Source payment records
|
|||||
| Pounce XL Thrombectomy Normalized: pounce xl thrombectomy |
Device | Surmodics, Inc. | $23.68 | 1 | 2025 |
Source payment records
|
|||||
| KYPHON EXPRESS II KYPHOPAK TRAY Normalized: kyphon express ii kyphopak tray |
Device | Medtronic, Inc. | $23.43 | 1 | 2025 |
Source payment records
|
|||||
| BROADWAY 8 Normalized: broadway 8 |
Device | Stryker Corporation | $23.28 | 1 | 2025 |
Source payment records
|
|||||
| CARDIVA VASCADE 5F VCS Normalized: cardiva vascade 5f vcs |
Device | CARDIVA MEDICAL, INC. | $23.19 | 1 | 2025 |
Source payment records
|
|||||
| WaveWriter Alpha Prime 16 Normalized: wavewriter alpha prime 16 |
Device | Boston Scientific Corporation | $21.55 | 1 | 2025 |
Source payment records
|
|||||
| ANGIO-SEAL Normalized: angio seal |
Device | Terumo Medical Corporation | $20.96 | 1 | 2025 |
Source payment records
|
|||||
| AZUR CX DETACHABLE Normalized: azur cx detachable |
Device | Terumo Medical Corporation | $20.96 | 1 | 2025 |
Source payment records
|
|||||
| GLIDEWIRE Normalized: glidewire |
Device | Terumo Medical Corporation | $20.96 | 1 | 2025 |
Source payment records
|
|||||
| NAVICROSS Normalized: navicross |
Device | Terumo Medical Corporation | $20.96 | 1 | 2025 |
Source payment records
|
|||||
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $20.37 | 1 | 2025 |
Source payment records
|
|||||
| MicroThermX Microwave Ablation System Normalized: microthermx microwave ablation system |
Device | Siemens Medical Solutions USA, Inc. | $20.01 | 1 | 2025 |
Source payment records
|
|||||
| INTELLIS ADAPTIVESTIM Normalized: intellis adaptivestim |
Device | Medtronic, Inc. | $20.00 | 1 | 2025 |
Source payment records
|
|||||
| MYNX CONTROL VENOUS Normalized: mynx control venous |
Device | CORDIS US CORP. | $18.66 | 1 | 2025 |
Source payment records
|
|||||
| JETSTREAM SC Normalized: jetstream sc |
Device | Boston Scientific Corporation | $17.61 | 1 | 2025 |
Source payment records
|
|||||
| ELUVIA Normalized: eluvia |
Device | Boston Scientific Corporation | $16.89 | 1 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Stryker Corporation | $16.05 | 1 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Stryker Corporation | $16.05 | 1 | 2025 |
Source payment records
|
|||||
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $15.11 | 1 | 2025 |
Source payment records
|
|||||
| ZOOM RDL RADIAL ACCESS SYSTEM, 103CM Normalized: zoom rdl radial access system 103cm |
Device | Imperative Care, Inc | $11.70 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $1,672.77 · 57 records | Imperative Care, Inc | ANGIO-SEAL, AURYON LASER SYSTEM 100-120 VAC, AZUR CX DETACHABLE, BROADWAY 8, CARDIVA VASCADE 5F VCS, CLOT MANAGEMENT, CLOTTRIEVER BOLD CATHETER, CT THROMBECTOMY SYSTEM KIT, Cryoablation needles, ELUVIA, EMBOLD Fibered, EMBOTRAP, ESPRIT, FLOWTRIEVER CATHETER, S, GLIDEWIRE, GORE VIABAHN Endoprosthesis with Heparin, GORE VIABIL Biliary Endoprosthesis, General - Embolics, HI-TORQUE COMMAND, ICEfx Cryoablation System, INTELLIS ADAPTIVESTIM, Indigo System, JETSTREAM SC, KYPHON EXPRESS II KYPHOPAK TRAY, MYNX CONTROL VENOUS, MicroThermX Microwave Ablation System, N/A, NAVICROSS, OSTEOCOOL RF ABLATION SYSTEM, Penumbra System, Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Pounce XL Thrombectomy, RED 72, SYMPHONY CATHETER, Serrantor, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, Sublime 014 Rx PTA Balloon Dilatation Catheter, Sublime Microcatheter, 018, 200cm, Straight, TRINAV INFUSION SYSTEM, Technical Education MRI, WaveWriter Alpha Prime 16, ZOOM 7X CATHETER, ZOOM 88-T LARGE DISTAL PLATFORM, ZOOM RDL RADIAL ACCESS SYSTEM, 103CM, ZOOM REPERFUSION CATHETER | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error